《新股表現》華營建築(01582.HK)暗盤收報2.28元 高上市價1.28倍
根據輝立交易平台顯示,明天掛牌的華營建築(01582.HK)暗盤開報1.5元,較上市價1元,高50%;最高見2.38元,收報2.28元,高上市價128%,成交797萬股,涉資1,600萬元。不計手續費,每手2,500股,賬面賺3,200元。
華營為本港樓宇建築總承建商。是次上市共發售1.39億股,並已引入包括華滋國際海洋工程(02258.HK)附屬忠德凱瑞等六名基石投資者,合共認購5,050萬股;10%公開發售獲近9倍超購,認購一手中籤率20%;股份以招股範圍(1-1.4元)下限定價,料集資淨額9,630萬元,主要用作撥付潛在樓宇建築工程前期成本及增強人手等。上市獨家保薦人第一上海。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.